EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Predicting the risk of venous thromboembolism in critically ill patients (PROVE-IT): a model development and validation study

Sean C S Rivrud, Èmese R H Heijkoop, Lisa Hulshof, Niels C Gritters van den Oever, Mik Wetterslev, Anders Perner, Frederik Keus, Karina Meijer, Ruben J Eck

Journal of Thrombosis and Haemostasis · 2025

DOI: 10.1016/j.jtha.2025.06.026 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Sean C S Rivrud und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care, University Medical Center Groningen, Groningen, the Netherlands; Department of Hematology, University Medical Center Gr…. Hauptthemen laut MEDLINE: Venous Thromboembolism, Decision Support Techniques. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSL Behring, Novo Nordisk Fonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Venous thromboembolism (VTE) is a serious complication of critical illness. The persistently high rates of VTE may be the result of thromboprophylaxis failure in critically ill patients at particularly high risk of VTE. A prognostic model may facilitate patient-specific interventions, ultimately lowering the incidence of VTE in critically ill patients. OBJECTIVES: We aimed to develop and externally validate a prognostic model for VTE in critically ill patients: Predicting the Risk of Venous Thromboembolism in Critically Ill Patients model. METHODS: The outcome was in-hospital VTE after intensive care unit admission. Model development was performed using multiple logistic regression with 14 established prognostic factors for VTE in critically ill patients. External validation was conducted in an independent cohort. Model performance was evaluated in terms of discrimination (C-statistic), calibration (integrated calibration index [ICI], E50, E90, Emax), and clinical utility (decision curve analysis [DCA]). RESULTS: The Predicting the Risk of Venous Thromboembolism in Critically Ill Patients (PROVE-IT) model was developed in 26 218 patients and externally validated in 1983 patients. Discrimination was acceptable with a C-statistic of 0.681 upon internal validation and 0.629 upon external validation. Calibration was excellent internally (ICI = 0.00231; E50 = 0.00184; E90 = 0.00313; Emax = 0.452) and good externally (ICI = 0.00664; E50 = 0.00447; E90 = 0.00131; Emax = 0.154). DCA suggested that the model may have clinical benefit over a range of risk thresholds (1.1%-4.7%), although not statistically significant. CONCLUSION: We developed and externally validated a prognostic model for in-hospital VTE in critically ill patients. Our model was well-calibrated upon external validation, although the discrimination was merely acceptable. Additionally, the model's clinical utility, assessed by DCA, is unclear, which precludes its recommendation for clinical implementation at this stage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venous ThromboembolismDecision Support TechniquesHumansCritical IllnessMaleFemaleMiddle AgedRisk FactorsRisk AssessmentAgedReproducibility of ResultsPrognosisIntensive Care UnitsLogistic ModelsPredictive Value of TestsAdultCalibration

Stichwörter der Autor:innen

critical illnessembolism and thrombosismodels, statisticalrisk assessmentvenous thromboembolism

Autor:innen und Institutionen

  • Department of Intensive Care, University Medical Center Groningen, Groningen, the Netherlands; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: s.c.s.rivrud@…
  • Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands.
  • Department of Anesthesiology, University Medical Center Groningen, Groningen, the Netherlands.
  • Department of Intensive Care, Treant, Emmen, the Netherlands.
  • Department of Intensive Care, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
  • Department of Intensive Care, University Medical Center Groningen, Groningen, the Netherlands.

Förderung

  • CSL Behring
  • Novo Nordisk Fonden

Zitieren

APA

Rivrud, S. C. S., Heijkoop, È. R. H., Hulshof, L., Gritters van den Oever, N. C., Wetterslev, M., Perner, A., Keus, F., Meijer, K., & Eck, R. J. (2025). Predicting the risk of venous thromboembolism in critically ill patients (PROVE-IT): a model development and validation study. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.06.026

Vancouver

Rivrud SCS, Heijkoop ÈRH, Hulshof L, Gritters van den Oever NC, Wetterslev M, Perner A, et al. Predicting the risk of venous thromboembolism in critically ill patients (PROVE-IT): a model development and validation study. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2025.06.026

BibTeX
@article{Rivrud2025,
  author = {Rivrud, Sean C S and Heijkoop, Èmese R H and Hulshof, Lisa and Gritters van den Oever, Niels C and Wetterslev, Mik and Perner, Anders and Keus, Frederik and Meijer, Karina and Eck, Ruben J},
  title = {Predicting the risk of venous thromboembolism in critically ill patients (PROVE-IT): a model development and validation study},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2025},
  doi = {10.1016/j.jtha.2025.06.026}
}
Kostenlos starten →